PH12010500880A1 - - Google Patents

Info

Publication number
PH12010500880A1
PH12010500880A1 PH12010500880A PH12010500880A PH12010500880A1 PH 12010500880 A1 PH12010500880 A1 PH 12010500880A1 PH 12010500880 A PH12010500880 A PH 12010500880A PH 12010500880 A PH12010500880 A PH 12010500880A PH 12010500880 A1 PH12010500880 A1 PH 12010500880A1
Authority
PH
Philippines
Application number
PH12010500880A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PH12010500880A1 publication Critical patent/PH12010500880A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/22—Valves or arrangement of valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PH12010500880A 2007-10-25 2008-10-27 PH12010500880A1 (https=)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0720967.9A GB0720967D0 (en) 2007-10-25 2007-10-25 Anti-material pharmaceutical composition
GBGB0806510.4A GB0806510D0 (en) 2007-10-25 2008-04-10 Anti-malarial pharmaceutical composition
PCT/GB2008/050999 WO2009053758A1 (en) 2007-10-25 2008-10-27 Anti-malarial pharmaceutical composition

Publications (1)

Publication Number Publication Date
PH12010500880A1 true PH12010500880A1 (https=) 2014-10-07

Family

ID=38829944

Family Applications (2)

Application Number Title Priority Date Filing Date
PH12010500880A PH12010500880A1 (https=) 2007-10-25 2008-10-27
PH12013501567A PH12013501567B1 (en) 2007-10-25 2013-07-24 Anti-malarial pharmaceutical composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH12013501567A PH12013501567B1 (en) 2007-10-25 2013-07-24 Anti-malarial pharmaceutical composition

Country Status (25)

Country Link
US (5) US20110015260A1 (https=)
EP (3) EP2209464B1 (https=)
JP (2) JP5438018B2 (https=)
CN (2) CN101835464B (https=)
AP (2) AP2920A (https=)
AU (1) AU2008315767B2 (https=)
BR (2) BR122013005952A2 (https=)
CA (1) CA2702506C (https=)
CY (1) CY1116759T1 (https=)
DK (1) DK2209464T3 (https=)
EA (2) EA026281B1 (https=)
ES (2) ES2540727T3 (https=)
GB (3) GB0720967D0 (https=)
HR (1) HRP20140773T1 (https=)
MX (1) MX2010004392A (https=)
MY (2) MY153119A (https=)
NZ (1) NZ584672A (https=)
PE (1) PE20091322A1 (https=)
PH (2) PH12010500880A1 (https=)
PL (1) PL2209464T3 (https=)
PT (1) PT2209464E (https=)
RS (1) RS53507B1 (https=)
SI (1) SI2209464T1 (https=)
WO (1) WO2009053758A1 (https=)
ZA (1) ZA201002607B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140256761A1 (en) * 2009-04-22 2014-09-11 Robert Lewis Steele Enhanced artemisinin-based combination therapy for treating parasitic mediated disease
GB2469792A (en) * 2009-04-23 2010-11-03 Calvin John Ross Oil-based pharmaceutical formulation for sublingual delivery
GB2469791B (en) * 2009-04-23 2011-12-14 Londonpharma Ltd Transmucosal formulation of compounds providing dihydroartemesinin for use in the treatment of neoplastic disease
JP2012524771A (ja) * 2009-04-23 2012-10-18 ロンドンファーマ リミテッド 中性油を含む舌下用の医薬組成物
US8290525B2 (en) 2010-01-15 2012-10-16 Comcast Cable Communications, Llc Text alternative to established voice call session
US8481757B2 (en) * 2010-02-04 2013-07-09 Georgua Tech Research Corporation Compounds and compositions useful in the treatment of malaria
US20140256762A1 (en) * 2012-07-06 2014-09-11 Robert Lewis Steele Artemisinin-based combination therapy for treating viral mediated disease
TWI733649B (zh) * 2014-03-07 2021-07-21 巴哈馬商克利普頓集團公司 用於治療寄生蟲介導疾病之強化的基於青蒿素組合療法
GB201414918D0 (en) * 2014-08-21 2014-10-08 Corbitt Terence Simon Formulations for transmucosal delivery
GB201414919D0 (en) * 2014-08-21 2014-10-08 Corbitt Terence Simon Formulations for transmucosal delivery
US20170326102A1 (en) * 2014-11-27 2017-11-16 Cipla Limited Pharmaceutical Composition Comprising an Artemisinin Derivative for Nasal or Pulmonary Delivery
US20220280734A1 (en) * 2021-03-07 2022-09-08 Sultan A. M. Daham Intaking an antiviral by inhalation or spraying for respiratory tract infection

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4869899A (en) * 1986-03-10 1989-09-26 Walter Burghart Pharmaceutical preparation and process for producing the same
US5057501A (en) * 1990-03-13 1991-10-15 Dermatologic Research Corporation Methods for treatment of papulosquamous and eczematous diseases
US20020099067A1 (en) * 1993-07-08 2002-07-25 Ulrich Posanski Pharmaceutical compositions for sparingly soluble therapeutic agents
US5578637A (en) * 1995-05-03 1996-11-26 University Of Washington Methods of inhibition or killing cancer cells using an endoperoxide
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
CH692321A5 (de) 1997-11-03 2002-05-15 Mepha Ag Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält.
RU2129809C1 (ru) * 1998-04-24 1999-05-10 Захарчук Анатолий Васильевич Способ получения пищевого продукта в капсулах
CN1084333C (zh) * 1998-06-17 2002-05-08 中国科学院上海药物研究所 新的青蒿素化合物,其制备方法以及含有它们的药物组合物
TR200100073T2 (tr) * 1998-07-14 2001-05-21 Bayer Aktiengeselkschaft Antiparazitik artemisinin türevleri (endoperoksitler)
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
ES2153786B1 (es) * 1999-06-10 2001-10-16 S A L V A T Lab Sa Composicion farmaceutica liquida para la administracion oral de principios activos amargos y susceptibles de hidrolisis.
FR2796276B1 (fr) * 1999-07-15 2003-05-16 Oreal Composition sous forme solide comprenant une huile et un compose gelifiant particulier, procede de traitement cosmetique et utilisation dudit compose
US6617356B2 (en) * 2000-01-03 2003-09-09 Naturally Scientific Inc Gel system for oral and topical administration of water insoluble and/or water intolerant drugs and supplements
JP3752127B2 (ja) * 2000-03-21 2006-03-08 花王株式会社 油脂組成物
WO2001091587A2 (en) * 2000-06-02 2001-12-06 Forbes Medi-Tech Inc. Oil compositions comprising short, medium and long chain triglycerides and use thereof in reducing weight gain
AU2001295979A1 (en) * 2000-10-20 2002-04-29 Ajinomoto Co., Inc. Medicinal compositions, dose and method for treating malaria
US6951846B2 (en) * 2002-03-07 2005-10-04 The United States Of America As Represented By The Secretary Of The Army Artemisinins with improved stability and bioavailability for therapeutic drug development and application
ATE482695T1 (de) * 2002-12-13 2010-10-15 Durect Corp Orale darreichungsform mit flüssigen hochviskosen trägersystemen
JP2004307428A (ja) * 2003-04-10 2004-11-04 Porien Project Kk 原虫感染症予防治療薬
US20050042281A1 (en) * 2003-08-21 2005-02-24 Singh Nikhilesh N. Compositions for delivering therapeutic agents across the oral mucosa
CA2578709C (en) * 2004-06-17 2010-06-15 Virun, Inc. Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agents
CN1650854A (zh) * 2004-12-08 2005-08-10 广州中生生物技术有限公司 一种含有蒿甲醚（或蒿乙醚或蒿琥酯）微乳剂的制备工艺
US20060233895A1 (en) * 2005-04-15 2006-10-19 Brown Paul R Herbal remedy for treating Lyme disease
US20060264458A1 (en) * 2005-05-03 2006-11-23 Jie Du Quinine dosage forms and methods of use thereof
CN101325944B (zh) * 2005-10-11 2013-01-16 耶路撒冷希伯来大学伊萨姆研究开发公司 用于鼻部给药的组合物
RU2432950C2 (ru) * 2006-01-25 2011-11-10 Инсис Терапьютикс Инк. Подъязычный спрей на основе фентанила
CN101310720A (zh) * 2007-05-22 2008-11-26 天津丹溪国药研究所 一种治疗疟疾的蒿甲醚滴丸剂的制备方法
CN101317839A (zh) * 2007-06-05 2008-12-10 天津丹溪国药研究所 一种治疗疟疾的复方蒿甲醚滴丸剂的制备方法
JP2012524771A (ja) * 2009-04-23 2012-10-18 ロンドンファーマ リミテッド 中性油を含む舌下用の医薬組成物
NZ595469A (en) * 2009-04-23 2013-10-25 Londonpharma Ltd Sublingual spray formulation comprising dihydroartemesinin
GB2483579A (en) * 2010-06-30 2012-03-14 Londonpharma Ltd Sublingual formulations comprising methadone and ethanol for use in reducing pain

Also Published As

Publication number Publication date
EP2653153B1 (en) 2015-05-27
CA2702506C (en) 2015-08-25
US20110015260A1 (en) 2011-01-20
PT2209464E (pt) 2014-09-05
EP2209464A1 (en) 2010-07-28
GB0720967D0 (en) 2007-12-05
GB2454567B (en) 2010-06-30
US20180071207A1 (en) 2018-03-15
PE20091322A1 (es) 2009-10-04
HRP20140773T1 (hr) 2014-11-07
JP2011500781A (ja) 2011-01-06
EA201300151A1 (ru) 2013-10-30
EP2209464B1 (en) 2014-06-04
EA201000497A1 (ru) 2010-12-30
EP2653153A1 (en) 2013-10-23
AU2008315767A1 (en) 2009-04-30
GB2454567A (en) 2009-05-13
AP2010005231A0 (en) 2010-04-30
CN103622950A (zh) 2014-03-12
CN101835464B (zh) 2013-05-15
GB0819559D0 (en) 2008-12-03
AU2008315767B2 (en) 2013-11-07
JP5438018B2 (ja) 2014-03-12
PL2209464T3 (pl) 2014-11-28
RS53507B1 (sr) 2015-02-27
CN103622950B (zh) 2016-05-04
NZ584672A (en) 2012-03-30
WO2009053758A1 (en) 2009-04-30
BRPI0817833A2 (pt) 2015-03-31
ZA201002607B (en) 2011-10-26
JP2014088400A (ja) 2014-05-15
CY1116759T1 (el) 2017-03-15
AP3542A (en) 2016-01-13
SI2209464T1 (sl) 2014-11-28
MX2010004392A (es) 2010-06-25
US20140179772A1 (en) 2014-06-26
MY153119A (en) 2014-12-31
CA2702506A1 (en) 2009-04-30
EA026281B1 (ru) 2017-03-31
ES2540727T3 (es) 2015-07-13
PH12013501567A1 (en) 2014-10-08
EA017804B1 (ru) 2013-03-29
DK2209464T3 (da) 2014-08-25
ES2494340T3 (es) 2014-09-15
HK1190645A1 (zh) 2014-07-11
BR122013005952A2 (pt) 2015-07-14
EP2749267A1 (en) 2014-07-02
AP2920A (en) 2014-05-31
US20190290576A1 (en) 2019-09-26
CN101835464A (zh) 2010-09-15
PH12013501567B1 (en) 2014-10-08
AP2013006997A0 (en) 2013-07-31
BRPI0817833A8 (pt) 2015-09-15
MY161745A (en) 2017-05-15
US20160038404A1 (en) 2016-02-11
GB0806510D0 (en) 2008-05-14

Similar Documents

Publication Publication Date Title
PH12010500880A1 (https=)
CN300729183S (zh) 渣水分离杯
CN300728402S (zh) 灯(acer-dl-asy-t)
CN300726478S (zh) 电视柜(tvt-23)
CN300726475S (zh) 衣柜(td-02)
CN300726247S (zh) 壁纸(9)
CN300915241S (zh) 糖罐
CN300868972S (zh) 鞋面
CN300846358S (zh) 排水泵电机及防护罩组合
CN300828079S (zh) 多用途生物显微镜(xsp-106)
CN300804373S (zh) 玩具(旋转游戏)
CN300795184S (zh) 油画棒
CN300783831S (zh) 便携式电动线锯(4327)
CN300767772S (zh) 剃须刀(sl3035)
CN300746151S (zh) 零钱袋(063045)
CN300734757S (zh) 书柜(fs9001)
CN300730387S (zh) 电梯用液晶显示器
CN300727567S (zh) 数码录音笔(vm420)
CN300727985S (zh) 标签(jmy-016)
CN300728300S (zh) 型材(ymgr5311)
CN300728316S (zh) 铜合金型材(1)
CN300726690S (zh) 晾衣架主机(s型)
CN300729431S (zh) 酒盒(1)
CN300729233S (zh) 小刀(0702)
CN300728451S (zh) 汽车前照灯